Diabetes Mellitus Secondary to Chronic Pancreatitis: Aspects of Clinical Course and Management
https://doi.org/10.31550/1727-2378-2023-22-4-59-63
Abstract
Aim: To demonstrate a clinical case of a patient with diabetes mellitus secondary to chronic pancreatitis, who needs not only compensation for carbohydrate metabolism, but also correction of exocrine pancreatic insufficiency.
Key points. The patient noted a significant improvement in well-being against the background of adequate hypoglycemic therapy (nighttime metformin, sodium-glucose co-transporter type 2 inhibitors and glucagon-like peptide-1 receptor agonist, basal insulin glargine) and enzyme-replacement therapy with pancreatin minimicrospheres at a dose of 50,000 IU on main meals and up to 25,000 ED at snacks. When evaluating the glycemic profile of continuous glucose monitoring showed stabilization of blood glucose at the target range. According to the results of laboratory tests, the patient showed not only normalization of carbohydrate metabolism, but also an initially reduced level of total protein, vitamins and minerals.
Conclusion. Administration of drugs used to treat patients with type 2 diabetes mellitus for the management of patients with diabetes secondary to chronic pancreatitis is justified. At the same time, the addition of insulin is often necessary. For this group of patients, the enzyme replacement therapy of exocrine pancreatic insufficiency is as important for the correction of metabolic disorders as the usual hypoglycemic therapy.
About the Authors
A. S. Ametov
Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
2/1 Barrikadnaya Str., build. 1, Moscow, 125993
E. Yu. Pashkova
Russian Medical Academy of Continuous Professional Education; Botkin Hospital
Russian Federation
Russian Federation
2/1 Barrikadnaya Str., build. 1, Moscow, 125993; 5 2nd Botkinsky pr-d, Moscow, 125284
K. A. Amikishieva
Russian Medical Academy of Continuous Professional Education; Botkin Hospital
Russian Federation
Russian Federation
2/1 Barrikadnaya Str., build. 1, Moscow, 125993; 5 2nd Botkinsky pr-d, Moscow, 125284
V. R. Gadzhiev
Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
2/1 Barrikadnaya Str., build. 1, Moscow, 125993
References
1. Ewald N., Kaufmann C., Raspe A., Kloer H.U. et al. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab. Res. R. 2012;28(4):338–42. DOI: 10.1002/dmrr.2260
2. Hart P.A., Bellin M.D., Andersen D.K., Bradley D. et al. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol. Hepatol. 2016;1(3):226–37. DOI: 10.1016/S2468-1253(16)30106-6
3. Zhu X., Liu D., Wei Q., Lin H. et al. New-onset diabetes mellitus after chronic pancreatitis diagnosis: a systematic review and meta-analysis. Pancreas. 2019;48(7):868–75. DOI: 10.1097/ MPA.0000000000001359
4. Bellin M.D., Whitcomb D.C., Abberbock J., Sherman S. et al. Patient and disease characteristics associated with the presence of diabetes mellitus in adults with chronic pancreatitis in the United States. Am. J. Gastroenterol. 2017;112(9):1457–65. DOI: 10.1038/ajg.2017.181
5. Machicado J.D., Chari S.T., Timmons L., Tang G. et al. A population-based evaluation of the natural history of chronic pancreatitis. Pancreatology. 2018;18(1):39–45. DOI: 10.1016/j.pan.2017.11.012
6. Dugic A., Hagström H., Dahlman I., Rutkowski W. et al. Postpancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes. United European Gastroenterol. J. 2023;11(1):79–91. DOI: 10.1002/ueg2.12344
7. Bhattamisra S.K., Siang T.C., Rong C.Y., Annan N.C. et al. Type-3c diabetes mellitus, diabetes of exocrine pancreas — an update. Curr. Diabetes Rev. 2019;15(5):382–94. DOI: 10.2174/1573399815666 190115145702
8. Woodmansey C., McGovern A.P., McCullough K.A., Whyte M.B. et al. Incidence, demographics, and clinical characteristics of diabetes of the exocrine pancreas (type 3c): a retrospective cohort study. Diabetes Care. 2017;40(11):1486–93. DOI: 10.2337/dc17-0542
9. Romagnuolo J., Talluri J., Kennard E., Sandhu B.S. et al. Clinical profile, etiology, and treatment of chronic pancreatitis in North American women: analysis of a large multicenter cohort. Pancreas. 2016;45(7):934–40. DOI: 10.1097/MPA.0000000000000616
10. Gardner T.B., Adler D.G., Forsmark C.E., Sauer B.G. et al. ACG Clinical guideline: chronic pancreatitis. Am. J. Gastroenterol. 2020;115(3):322–39. DOI: 10.14309/ajg.0000000000000535
11. Makuc J. Management of pancreatogenic diabetes: challenges and solutions. Diabetes Metab. Syndr. Obes. 2016;9:311–15. DOI: 10.2147/DMSO.S99701
12. Martínez J., Abad-González Á., Aparicio J.R., Aparisi L. et al. Recommendations of the Spanish Pancreatic Club on the diagnosis and treatment of chronic pancreatitis: part 1 (diagnosis). Gastroenterol. Hepatol. 2013;36(5):326–39. DOI: 10.1016/j.gastrohep.2012.12.004
13. Qi L., Wei Q., Ni M., Liu D. et al. Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus. Diabetes Metab. 2022;48(3):101316. DOI: 10.1016/j.diabet.2021.101316
14. Lin Y.K., Johnston P.C., Arce K., Hatipoglu B.A. Chronic pancreatitis and diabetes mellitus. Curr. Treat. Options Gastroenteroly. 2015;13(3):319–31. DOI: 10.1007/s11938-015-0055-x
15. La Grotta R., de Candia P., Olivieri F., Matacchione G. et al. Antiinflammatory effect of SGLT-2 inhibitors via uric acid and insulin. Cell. Mol. Life Sci. 2022;79(5):273. DOI: 10.1007/s00018-022-04289-z
16. Zhao Z., Liu W. Pancreatic cancer: a review of risk factors, diagnosis, and treatment. Technol. Cancer Res. Treat. 2020;19:1533033820962117. DOI: 10.1177/1533033820962117
17. Hart P.A., Conwell D.L. Chronic pancreatitis: managing a difficult disease. Am. J. Gastroenterol. 2020;115(1):49–55. DOI: 10.14309/ajg.0000000000000421
18. Dominguez-Muñoz J.E. Diagnosis and treatment of pancreatic exocrine insufficiency. Curr. Opin. Gastroenterol. 2018;34(5):349– 54. DOI: 10.1097/MOG.0000000000000459
Review
For citations:
Ametov A.S., Pashkova E.Yu., Amikishieva K.A., Gadzhiev V.R. Diabetes Mellitus Secondary to Chronic Pancreatitis: Aspects of Clinical Course and Management. Title. 2023;22(4):59-63. (In Russ.) https://doi.org/10.31550/1727-2378-2023-22-4-59-63
Views:
10
Email this article 